273 related articles for article (PubMed ID: 19200841)
21. The immunogenicity and protective efficacy of Mtb8.4/hIL-12 chimeric gene vaccine.
Li H; Li R; Zhong S; Ren H; Zou Y; Chen X; Shi X; Wang M; Long H; Luo Y
Vaccine; 2006 Feb; 24(9):1315-23. PubMed ID: 16219397
[TBL] [Abstract][Full Text] [Related]
22. The safety of post-exposure vaccination of mice infected with Mycobacterium tuberculosis.
Derrick SC; Perera LP; Dheenadhayalan V; Yang A; Kolibab K; Morris SL
Vaccine; 2008 Nov; 26(48):6092-8. PubMed ID: 18809446
[TBL] [Abstract][Full Text] [Related]
23. Cell-mediated immune responses and protective efficacy against infection with Mycobacterium tuberculosis induced by Hsp65 and hIL-2 fusion protein in mice.
Shi C; Yuan S; Zhang H; Zhang T; Wang L; Xu Z
Scand J Immunol; 2009 Feb; 69(2):140-9. PubMed ID: 19144078
[TBL] [Abstract][Full Text] [Related]
24. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
Langermans JA; Doherty TM; Vervenne RA; van der Laan T; Lyashchenko K; Greenwald R; Agger EM; Aagaard C; Weiler H; van Soolingen D; Dalemans W; Thomas AW; Andersen P
Vaccine; 2005 Apr; 23(21):2740-50. PubMed ID: 15780721
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy.
Zárate-Bladés CR; Bonato VL; da Silveira EL; Oliveira e Paula M; Junta CM; Sandrin-Garcia P; Fachin AL; Mello SS; Cardoso RS; Galetti FC; Coelho-Castelo AA; Ramos SG; Donadi EA; Sakamoto-Hojo ET; Passos GA; Silva CL
J Gene Med; 2009 Jan; 11(1):66-78. PubMed ID: 19035575
[TBL] [Abstract][Full Text] [Related]
26. New alternative vaccine component against mycobacterium tuberculosis--heat shock protein 16.3 or its T-cell epitope.
Shi C; Zhang H; Zhang T; Wang X; Bai B; Zhao Y; Zhang C; Xu Z
Scand J Immunol; 2009 Nov; 70(5):465-74. PubMed ID: 19874551
[TBL] [Abstract][Full Text] [Related]
27. An attenuated Salmonella-vectored vaccine elicits protective immunity against Mycobacterium tuberculosis.
Wang QL; Pan Q; Ma Y; Wang K; Sun P; Liu S; Zhang XL
Vaccine; 2009 Nov; 27(48):6712-22. PubMed ID: 19733584
[TBL] [Abstract][Full Text] [Related]
28. Novel prophylactic vaccine using a prime-boost method and hemagglutinating virus of Japan-envelope against tuberculosis.
Okada M; Kita Y; Nakajima T; Kanamaru N; Hashimoto S; Nagasawa T; Kaneda Y; Yoshida S; Nishida Y; Nakatani H; Takao K; Kishigami C; Nishimatsu S; Sekine Y; Inoue Y; McMurray DN; Sakatani M
Clin Dev Immunol; 2011; 2011():549281. PubMed ID: 21437226
[TBL] [Abstract][Full Text] [Related]
29. Treatment of multi-drug-resistant tuberculosis in mice with DNA vaccines alone or in combination with chemotherapeutic drugs.
Liang Y; Wu X; Zhang J; Yang Y; Wang L; Bai X; Yu Q; Li N; Li Z
Scand J Immunol; 2011 Jul; 74(1):42-6. PubMed ID: 21352251
[TBL] [Abstract][Full Text] [Related]
30. Vaccine adjuvant: it makes the difference.
Lima KM; dos Santos SA; Rodrigues JM; Silva CL
Vaccine; 2004 Jun; 22(19):2374-9. PubMed ID: 15193397
[TBL] [Abstract][Full Text] [Related]
31. Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice.
Silva CL; Bonato VL; Coelho-Castelo AA; De Souza AO; Santos SA; Lima KM; Faccioli LH; Rodrigues JM
Gene Ther; 2005 Feb; 12(3):281-7. PubMed ID: 15526006
[TBL] [Abstract][Full Text] [Related]
32. Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis.
Lima KM; Santos SA; Lima VM; Coelho-Castelo AA; Rodrigues JM; Silva CL
Gene Ther; 2003 Apr; 10(8):678-85. PubMed ID: 12692596
[TBL] [Abstract][Full Text] [Related]
33. Immune modulation induced by tuberculosis DNA vaccine protects non-obese diabetic mice from diabetes progression.
Santos Júnior RR; Sartori A; Bonato VL; Coelho Castelo AA; Vilella CA; Zollner RL; Silva CL
Clin Exp Immunol; 2007 Sep; 149(3):570-8. PubMed ID: 17590177
[TBL] [Abstract][Full Text] [Related]
34. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
Fan X; Gao Q; Fu R
Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
[TBL] [Abstract][Full Text] [Related]
35. Mtb32 is a promising tuberculosis antigen for DNA vaccination in pre- and post-exposure mouse models.
Ahn SS; Jeon BY; Kim KS; Kwack JY; Lee EG; Park KS; Sung YC; Cho SN
Gene Ther; 2012 May; 19(5):570-5. PubMed ID: 21956689
[TBL] [Abstract][Full Text] [Related]
36. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
Yi H; Rong Y; Yankai Z; Wentao L; Hongxia Z; Jie W; Rongyue C; Taiming L; Jingjing L
Vaccine; 2006 Mar; 24(14):2575-84. PubMed ID: 16420967
[TBL] [Abstract][Full Text] [Related]
37. DNAhsp65 vaccination induces protection in mice against Paracoccidioides brasiliensis infection.
Ribeiro AM; Bocca AL; Amaral AC; Faccioli LH; Galetti FC; Zárate-Bladés CR; Figueiredo F; Silva CL; Felipe MS
Vaccine; 2009 Jan; 27(4):606-13. PubMed ID: 19028537
[TBL] [Abstract][Full Text] [Related]
38. Comparison of immune responses induced in mice by vaccination with DNA vaccine constructs expressing mycobacterial antigen 85A and interleukin-21 and Bacillus Galmette-Guérin.
Dou J; Tang Q; Zhao F; Chu L; Chen J; Cao M; Liu C; Wang Y; Li Y; Li JL
Immunol Invest; 2008; 37(2):113-27. PubMed ID: 18300037
[TBL] [Abstract][Full Text] [Related]
39. The death and resurrection of tuberculosis.
Bloom BR; McKinney JD
Nat Med; 1999 Aug; 5(8):872-4. PubMed ID: 10426305
[No Abstract] [Full Text] [Related]
40. Therapeutic DNA vaccines against tuberculosis: a promising but arduous task.
Li JM; Zhu DY
Chin Med J (Engl); 2006 Jul; 119(13):1103-7. PubMed ID: 16834929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
